Policy decision-making over the use of or government mandate for generic drug substitutes
remains at the forefront of health care. 1 High prescription drug prices are a major …

As was discussed in the first articles in this series (see AHDB, April, May 2008), generic
medications are positively affecting trends in pharmacy spending and, ultimately, overall …

The article offers information on the scope of generic drugs development in US Topics
discussed include estimation of use of generic drugs to be as large as dollar 1.67 trillion …

Since enactment of the Hatch-Waxman Act 25 years ago, the generic drug industry in the
United States has grown exponentially. Generic drugs now account for 70% of prescriptions …

On n Sept. 24, 1984, President Reagan signed a law simplifying FDA's approval process for
substitute, or" generic," versions of brand-name drugs whose patents have expired. With the …

Prescription drugs can be divided into two categories: innovator drugs and generic drugs.
Innovator drugs (also referred as brand-name drugs) generally have a patent on their …

With some biologic drugs costing up to $100,000 a year for rare disorders, generics offer the
promise of lower costs. The stakes are huge: Biotech drug sales are expected to exceed $60 …

The regulatory issues surrounding generic drug approval are increasingly challenging with
the emergence of biosimilar drug products. Ensuring the quality and integrity of a generic …

What Are Generic Drugs? Once a new drug is approved, the pharmaceutical company
receives an exclusive right to market that drug for a guaranteed minimum of 5 to 7 years …

Forms, was published in 2005 by Marcel Dekker, Inc., New York, as part of their series in
drugs and the pharmaceutical sciences. The objective of the first book was to describe, from …